Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis.
Ciapponi, A; Berrueta, M; Ballivian, J; Bardach, A; Mazzoni, A; Anderson, S; Argento, FJ; Bok, K; Comandé, D; Goucher, E; KAMPMANN, B; PARKER, EP K; Rodriguez-Cairoli, F; Santa Maria, V; Stergachis, A; Voss, G; Xiong, X; Zaraa, S; Munoz, FM; Karron, RA; Gottlieb, SL; Buekens, PM;
2023
Medicine, (2023).102 9 10.1097/MD.0000000000032954.
Linked poliovirus incidents in the UK, USA and Israel: Silent transmission or missed warnings of vaccine inequity?.
Kasstan, B; CHANTLER, T; Marcus, B; MOUNIER-JACK, S; Saliba, V; Edelstein, M;
2023
Vaccine, (2023).41 14 10.1016/j.vaccine.2023.02.043.
Cost-effectiveness of tuberculosis infection prevention and control interventions in South African clinics: a model-based economic evaluation informed by complexity science methods.
BOZZANI, FM; MCCREESH, N; Diaconu, K; GOVENDER, I; WHITE, RG; Kielmann, K; GRANT, AD; VASSALL, A;
2023
BMJ Global Health, (2023).8 2 10.1136/bmjgh-2022-010306.
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study.
OpenSAFELY Collaborative,; PARKER, EP; TAZARE, J; Hulme, WJ; Bates, C; Carr, EJ; Cockburn, J; Curtis, HJ; Fisher, L; Green, AC; Harper, S; Hester, F; Horne, EM; Loud, F; Lyon, S; MAHALINGASIVAM, V; Mehrkar, A; Nab, L; Parry, J; Santhakumaran, S; Steenkamp, R; Sterne, JA; Walker, AJ; WILLIAMSON, EJ; Willicombe, M; ... TOMLINSON, LA.
2023
BMJ Open, (2023).13 1 10.1136/bmjopen-2022-066164.
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
Portnoy, A; CLARK, RA; Quaife, M; WEERASURIYA, CK; Mukandavire, C; Bakker, R; Deol, AK; Malhotra, S; Gebreselassie, N; Zignol, M; Sim, SY; Hutubessy, RC W; Baena, IG; Nishikiori, N; JIT, M; WHITE, RG; Menzies, NA;
2023
PLOS Medicine, (2023).20 1 10.1371/journal.pmed.1004155.
Challenges in estimating waning effectiveness of two doses of BNT162b2 and ChAdOx1 COVID-19 vaccines beyond six months: an OpenSAFELY cohort study using linked electronic health records.
Horne, EM F; Hulme, W; KEOGH, R; Palmer, T; WILLIAMSON, E; PARKER, EP K; Walker, V; Knight, R; Wei, Y; Taylor, K; Fisher, L; Morley, J; Mehrkar, A; Dillingham, I; Bacon, S; GOLDACRE, B; Sterne, JA C; The OpenSAFELY Collaborative,;
2023
medRxiv (2023). 10.1101/2023.01.04.22283762.
First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY.
Hopcroft, L; Curtis, H; Brown, A; Hulme, W; Andrews, C; Morton, C; Inglesby, P; Morley, J; Mehrkar, A; Bacon, S; EGGO, R; MAHALINGASIVAM, V; PARKER, E; TOMLINSON, L; Bates, C; Cockburn, J; Parry, J; Hester, F; Harper, S; GOLDACRE, B; Walker, A; MacKenna, B;
2023
Wellcome Open Res (2023). 10.12688/wellcomeopenres.18735.2.
Investigate Non-EPI Vaccination Recommendation Practice from a Socio-Ecological Perspective: A Mixed-Methods Study in China.
Han, K; Hou, Z; Tu, S; Wang, Q; Wang, B; Liu, X; Jiang, S; CHANTLER, T; LARSON, H;
2022
Vaccines, (2022).10 12 10.3390/vaccines10122105.
The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries.
Portnoy, A; Arcand, J-L; Clark, R; WEERASURIYA, C; Mukandavire, C; Bakker, R; Patouillard, E; Gebreselassie, N; Zignol, M; JIT, M; WHITE, R; Menzies, N;
2022
medRxiv (2022). 10.1101/2022.11.23.22282690.
Variance-based sensitivity analysis of tuberculosis transmission models.
SUMNER, T; WHITE, RG;
2022
Journal of the Royal Society, Interface, (2022).19 196 10.1098/rsif.2022.0413.